Drug Name: Semaglutide Manufacturer: Novo Nordisk Type: GLP-1 agonist Brand Names: Ozempic = Type 2 Diabetes, weekly injection (approved December, 2017) Rebylsus = Type 2 Diabetes, daily pill (approved September, 2019) Wegovy = Weight Loss, weekly injection (approved June, 2021) Drug Name: Tirzepatide Manufacturer: Eli Lilly Type: GLP-1/GIP co-agonist Brand Names: Mounjaro = Type 2 Diabetes, weekly injection (approved May, 2022) Zepbound = Weight Loss Application, weekly injection (approved November, 2023) (No pill form exists as of this writing) The short story is that both drugs were originally introduced as effective Type 2 Diabetes medications
The 150 genetic insights across 14 pathways and 49 peptides in the Peptide Pathways Report are the foundational data set for that standard run on the Illumina Global Screening Array through CLIA-certified laboratories, delivered securely through the PlexusDx Results Portal, and relevant for every protocol decision you make going forward
Use is generally restricted to approved age groups where evidence supports safety
Dec 2015;13(12):787-92
The union railed against the decision to end the DPS partnership on Twitter, calling it "unconscionable" and saying that "public safety is not a priority" at City Hall
